Combination of treosulfan, fludarabine and cytarabine as conditioning in patients with acute myeloid leukemia, myelodysplastic syndrome and myeloproliferative neoplasms

被引：0
|
作者：
Samantha O‘Hagan Henderson
Jochen J. Frietsch
Inken Hilgendorf
Andreas Hochhaus
Claus-Henning Köhne
Jochen Casper
机构：
[1] Universitätsklinikum Oldenburg,Onkologie und Hämatologie
[2] Klinik Für Innere Medizin II,Abteilung Hämatologie und Internistische Onkologie
[3] Universitätsklinikum Jena,undefined
[4] Klinik Für Innere Medizin II,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2022年 / 148卷
关键词：
AML; MDS; MPN; Allogeneic stem cell transplantation; Toxicity-reduced conditioning;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2599 / 2609
页数：10
相关论文
共 50 条
  • [21] Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome
    van Besien, K
    Artz, A
    Smith, S
    Cao, D
    Rich, S
    Godley, L
    Jones, D
    Del Cerro, P
    Bennett, D
    Casey, B
    Odenike, O
    Thirman, M
    Daugherty, C
    Wickrema, A
    Zimmerman, T
    Larson, RA
    Stock, W
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (24) : 5728 - 5738
  • [22] Hematopoietic Cell Transplantation after TBI, Fludarabine, Idarubicine and Cytarabine Myeloablative Conditioning in Patients with Acute Myeloid Leukemia
    Vydra, Jan
    Valkova, Veronika
    Markova, Marketa Stastna
    Novakova, Ludmila
    Schwarz, Jiri
    Alek, Cyril
    Vitek, Antonin
    Cetkovsky, Petr
    Cermak, Jaroslav
    Michalova, Kyra
    BLOOD, 2014, 124 (21)
  • [23] Treosulfan, Fludarabine, and 2-Gy Total Body Irradiation Followed by Allogeneic Hematopoietic Cell Transplantation in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia
    Gyurkocza, Boglarka
    Gutman, Jonathan
    Nemecek, Eneida R.
    Bar, Merav
    Milano, Filippo
    Ramakrishnan, Aravind
    Scott, Bart
    Fang, Min
    Wood, Brent
    Pagel, John M.
    Baumgart, Joachim
    Delaney, Colleen
    Maziarz, Richard T.
    Sandmaier, Brenda M.
    Estey, Elihu H.
    Appelbaum, Frederick R.
    Storer, Barry E.
    Deeg, Hans Joachim
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (04) : 549 - 555
  • [24] Tipifarnib in combination with idarubicin and cytarabine in patients with newly diagnosed acute myeloid leukemia (AML) or high risk myelodysplastic syndrome (MDS).
    Ravandi-Kashani, F.
    Kantarjian, H.
    Garcia-Manero, G.
    O'Brien, S.
    Verstovsek, S.
    Estrov, Z.
    Faderl, S.
    Giles, F.
    Wright, J.
    Cortes, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 351S - 351S
  • [25] Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS)
    N Kröger
    A Shimoni
    T Zabelina
    H Schieder
    J Panse
    F Ayuk
    C Wolschke
    H Renges
    J Dahlke
    D Atanackovic
    A Nagler
    A Zander
    Bone Marrow Transplantation, 2006, 37 : 339 - 344
  • [26] Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS)
    Kröger, N
    Shimoni, A
    Zabelina, T
    Schieder, H
    Panse, J
    Ayuk, F
    Wolschke, C
    Renges, H
    Dahlke, J
    Atanackovic, D
    Nagler, A
    Zander, A
    BONE MARROW TRANSPLANTATION, 2006, 37 (04) : 339 - 344
  • [27] Myelodysplastic syndrome and acute myeloid leukemia after treatment with fludarabine, mitoxantrone, and dexamethasone
    Au, WY
    Chan, LC
    Liang, R
    Kwong, YL
    AMERICAN JOURNAL OF HEMATOLOGY, 2006, 81 (06) : 471 - 473
  • [28] Fludarabine and cytarabine as continuous sequential infusion for elderly patients with acute myeloid leukemia
    Ferrara, Felicetto
    D'Arco, Alfonso M.
    De Simone, Mariacarla
    Mele, Giuseppina
    Califano, Catello
    Pocali, Barbara
    Danise, Paolo
    Palmieri, Salvatore
    HAEMATOLOGICA, 2005, 90 (06) : 776 - 784
  • [29] Twice-Daily Fludarabine and Cytarabine Combination With or Without Gentuzumab Ozogamicin is Effective in Patients With Relapsed/Refractory Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, and Blast- Phase Chronic Myeloid Leukemia
    Jabbour, Elias
    Garcia-Manero, Guillermo
    Cortes, Jorge
    Ravandi, Farhad
    Plunkett, William
    Gandhi, Varsha
    Faderl, Stefan
    O'Brien, Susan
    Borthakur, Gautam
    Kadia, Tapan
    Burger, Jan
    Konopleva, Marina
    Brandt, Mark
    Huang, Xuelin
    Kantarjian, Hagop
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2012, 12 (04): : 244 - 251
  • [30] TREOSULFAN PLUS FLUDARABINE "REDUCED INTENSITY CONDITIONING" WITH POSTTRANSPLANT CYCLOPHOSPHAMIDE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA OLDER THAN 65 YEARS
    Federico, Vincenzo
    Matera, Rosella
    Salvatore, Dalila
    Canale, Filippo Antonio
    Merla, Manuela
    Valente, Daniela
    Contento, Corine
    Campagna, Giulia
    Vaddinelli, Doriana
    Natale, Annalisa
    Seripa, Davide
    Santarone, Stella
    Grassi, Tiziana
    Bagordo, Francesco
    Di Renzo, Nicola
    Martino, Massimo
    Carella, Angelo Michele
    BONE MARROW TRANSPLANTATION, 2024, 59 : 537 - 538
12345